Evidence map›Paper›PMID 33301228›Full record

ArticleChemMedChem2021

Tautomycetin Synthetic Analogues: Selective Inhibitors of Protein Phosphatase I.

Zachary R Woydziak, A John Yucel, A Richard Chamberlin

Open access · greenAbstract read
In one paragraph

Article in ChemMedChem, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Role of serine/threonine phosphatases 1 and 2A in pancreatic acinar fluid and electrolyte secretion.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zachary R WoydziakDepartment of Physical and Life Sciences, Nevada State College, 1300, Nevada State Dr., Henderson, NV 89002, USA.ORCID 0000-0002-7842-4802
A John YucelDepartment of Pharmaceutical Sciences, University of California, Irvine, 147 Biol. Sci. Admin., Irvine, CA 92697, USA.
A Richard ChamberlinDepartment of Pharmaceutical Sciences, University of California, Irvine, 147 Biol. Sci. Admin., Irvine, CA 92697, USA.
University of California, Irvine · USNevada State University · US

Funding

Outreach/Diversity/Pipeline ProjectP20GM103440 · NIGMS · UNIVERSITY OF NEVADA RENO · PI Julia Petereit · 2012 to 2026
$58.0M
NEW SIGNALING PATHWAY PROBES BASED ON NATURAL TOXINSR01GM057550 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI CHAMBERLIN, A RICHARD · 1998 to 2007
$1.5M
NIGMS NIH HHS P20 GM103440NIGMS NIH HHS R01 GM057550NIH HHS 2P20GM103440-14A1
6 · The paper itself

Abstract

Ser/Thr protein phosphatases (PPs) regulate a substantial range of cellular processes with protein phosphatases 1 (PP1) and 2 A (PP2A) accounting for over 90 % of the activity within cells. Nevertheless, tools to study PPs are limited as PPs inhibitors, particularly those selective for PP1 inhibition, are relatively scarce. Two examples of PP1-selective inhibitors, which share structural similarities, are tautomycin (TTM) and tautomycetin (TTN). This work describes the development of PP1/PP2A inhibitors that incorporate key structural features of TTM and TTN and are designed to conserve regions known to bind the active site of PP1/PP2A but vary regions that differentially contact the hydrophobic groove of PP1/PP2A. In all 28 TTN analogues were synthetically generated that inhibit PP1/PP2A activity at <250 mM; seven possessed inhibition activity at 100 nM. The IC

Indexed as

Dose-Response Relationship, DrugEnzyme InhibitorsFuransHumansLipidsMolecular StructureProtein Phosphatase 2Receptors, Neuropeptide YStructure-Activity RelationshipEnzyme InhibitorsFuransLipidsneuropeptide Y4 receptorPPP2CA protein, humanProtein Phosphatase 2Receptors, Neuropeptide Ytautomycetininhibitorsprotein phosphatasesserinetautomycetintautomycinthreonine

Identifiers

PMID33301228
PMCPMC8582298
OpenAlexW3112394496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.